Erwin Rieder1, Anneliese Steinacher-Nigisch2, Günter Weigel3. 1. Department of Surgery, Medical University of Vienna, Austria. 2. Surgical Research Laboratories, Medical University of Vienna, Austria. 3. Institute of Medical and Chemical Laboratory Diagnostics, University Hospital, Innsbruck, Austria. Electronic address: guenter.weigel@tirol-kliniken.at.
Abstract
BACKGROUND: Immunological knowledge on processed biological implants and mesh-prostheses is still mainly based on animal models, lacking information on the species-specific human immune response. We hypothesized that in contrast to human tissue even decellularized xenogenic specimens would lead to significant and tissue source dependent human immune reactions. METHODS: Specimens from processed allogenic and xenogenic pulmonary arteries, pericardium or dermis, were co-cultured with human peripheral blood mononuclear cells (PBMNC). Proliferative responses were measured in tritiated thymidine incorporation assays (n = 10). Stimulation indices (SI), calculated as counts-per-minute of co-cultured PBMNC divided by the cpm of basic cell proliferation, were compared. RESULTS: Compared to native porcine pulmonary artery tissue decellularization significantly reduced human PBMNC proliferation (mean SI: 48.7 vs. 18.0, p < 0.01), which was still higher compared to the human equivalent (SI: 0.7 vs. 1.7). Also the processed human dermal implant did not elicit immune response (SI: 1.5), whereas the decellularized and cross-linked porcine dermis lead to a significant human cell-proliferation (SI: 8.4, p < 0.01). Interestingly, both the processed human (SI: 15.2) and bovine pericardial patches (SI: 15.1) led to higher immune cell proliferation. CONCLUSION: Even decellularized or cross-linked xenogenic cardiovascular and reconstructive biomaterials elicit increased human immune responses not seen in the majority of allogenic specimens tested.
BACKGROUND: Immunological knowledge on processed biological implants and mesh-prostheses is still mainly based on animal models, lacking information on the species-specific human immune response. We hypothesized that in contrast to human tissue even decellularized xenogenic specimens would lead to significant and tissue source dependent human immune reactions. METHODS: Specimens from processed allogenic and xenogenic pulmonary arteries, pericardium or dermis, were co-cultured with human peripheral blood mononuclear cells (PBMNC). Proliferative responses were measured in tritiated thymidine incorporation assays (n = 10). Stimulation indices (SI), calculated as counts-per-minute of co-cultured PBMNC divided by the cpm of basic cell proliferation, were compared. RESULTS: Compared to native porcine pulmonary artery tissue decellularization significantly reduced human PBMNC proliferation (mean SI: 48.7 vs. 18.0, p < 0.01), which was still higher compared to the human equivalent (SI: 0.7 vs. 1.7). Also the processed human dermal implant did not elicit immune response (SI: 1.5), whereas the decellularized and cross-linked porcine dermis lead to a significant human cell-proliferation (SI: 8.4, p < 0.01). Interestingly, both the processed human (SI: 15.2) and bovine pericardial patches (SI: 15.1) led to higher immune cell proliferation. CONCLUSION: Even decellularized or cross-linked xenogenic cardiovascular and reconstructive biomaterials elicit increased human immune responses not seen in the majority of allogenic specimens tested.
Authors: Joel L Berry; Wuqiang Zhu; Yao Liang Tang; Prasanna Krishnamurthy; Ying Ge; John P Cooke; Yabing Chen; Daniel J Garry; Huang-Tian Yang; Namakkal Soorapan Rajasekaran; Walter J Koch; Song Li; Keitaro Domae; Gangjian Qin; Ke Cheng; Timothy J Kamp; Lei Ye; Shijun Hu; Brenda M Ogle; Jack M Rogers; E Dale Abel; Michael E Davis; Sumanth D Prabhu; Ronglih Liao; William T Pu; Yibin Wang; Peipei Ping; Nenad Bursac; Gordana Vunjak-Novakovic; Joseph C Wu; Roberto Bolli; Philippe Menasché; Jianyi Zhang Journal: Circ Res Date: 2019-01-04 Impact factor: 17.367
Authors: Ramon E Coronado; Maria Somaraki-Cormier; Shanmugasundaram Natesan; Robert J Christy; Joo L Ong; Glenn A Halff Journal: Cell Transplant Date: 2017-12 Impact factor: 4.064